Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Ruboxistaurin reduces the risk of vision loss in diabetic retinopathy

Nov. 29, 2006

Adalimumab may be effective for the treatment of refractory uveitis

Nov. 27, 2006

Preclinical and clinical efficacy of different antiangiogenic strategies for the management of CNV

Nov. 24, 2006

Snapshots of recent studies of bevacizumab on AMD and related conditions

Nov. 23, 2006

Treatment update on macular edema: snapshots of recent studies

Nov. 22, 2006

Lucentis recommended for approval in E.U. for wet AMD

Nov. 20, 2006

New agent for glaucoma disclosed in recent Johns Hopkins University patent

Nov. 15, 2006

SPI-0023: a novel ciclosporin formulation for ophthalmic use

Nov. 14, 2006

AzaSite Plus begins phase I safety study

Nov. 10, 2006

OcuCure uses seed funding to advance compounds for AMD

Nov. 10, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...